The strain was adapted on Vero cells by multiple passages and plaque isolated. The strain B5 - 203P-2013-P10.1 was selected as a candidate strain for the HFMD vaccine due to possessing genetic stability, high titer of 108 TCID50 / ml and cross-neutralising antibody responses against other subgenogroups B5, C4, C5.